‹ Screener

MiNK Therapeutics, Inc.

INKT · Biological Products, (No Diagnostic Substances) · 5.0M shares · -47%/yr ↓ buyback · EDGAR filings ↗

Reference price $12.68 · est. market cap ~$63M — last insider sale, 2026-06-04 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D40

Clinical/early-stage biotech — iNKT cell-therapy clinical with negative equity, thin liquidity.

Strengths

Risks

Notable findings

Key metrics

Return on equity
87.8%
Return on assets
-87.7%
Interest coverage
114.9×
Current ratio
1.1×
Tangible book value
-$14M
Cash & investments
$13M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-04Ryan BarbaraSell500$12.68
2026-06-04Ryan BarbaraSell1.0K$12.80
2026-06-01Ryan BarbaraGrant1.4K$12.38
2026-06-01WIINBERG ULFGrant1.1K$12.38
2026-06-01Holcomb John BradleyGrant1.1K$12.38
2026-06-01Corvese BrianGrant1.4K$12.38
2026-06-01Behner PeterGrant1.3K$12.38
2026-03-10Ryan BarbaraSell500$15.57
2026-03-10Ryan BarbaraSell500$15.30
2026-03-10Ryan BarbaraSell300$15.28
2026-03-09Ryan BarbaraSell200$10.17
2026-03-02WIINBERG ULFGrant1.3K$10.90
2026-03-02Holcomb John BradleyGrant1.2K$10.90
2026-03-02Ryan BarbaraGrant1.6K$10.90
2026-03-02Corvese BrianGrant1.6K$10.90
2026-03-02Behner PeterGrant1.5K$10.90
2026-03-02Ryan BarbaraSell100$10.83
2026-02-27Ryan BarbaraSell400$10.86
2026-01-02Buell JenniferGrant31K$11.12
2026-01-02Buell JenniferTax withheld10K$11.12
2025-12-01Behner PeterGrant1.5K$11.09
2025-12-01Corvese BrianGrant1.6K$11.09
2025-12-01Holcomb John BradleyGrant1.1K$11.09
2025-12-01Ryan BarbaraGrant1.6K$11.09
2025-12-01Kadlec Robert PeterGrant1.2K$11.09
2025-12-01WIINBERG ULFGrant1.3K$11.09
2025-09-09Buell JenniferTax withheld5.4K$15.36
2025-09-09Buell JenniferGrant18K$15.36
2025-09-02WIINBERG ULFGrant1.0K$13.86
2025-09-02Kadlec Robert PeterGrant975$13.86
2025-09-02Ryan BarbaraGrant1.3K$13.86
2025-09-02Corvese BrianGrant1.3K$13.86
2025-09-02Behner PeterGrant1.2K$13.86
2025-06-02Behner PeterGrant2.3K$7.17
2025-06-02WIINBERG ULFGrant2.0K$7.17
2025-06-02Corvese BrianGrant2.5K$7.17
2025-06-02Kadlec Robert PeterGrant1.9K$7.17
2025-06-02Ryan BarbaraGrant2.5K$7.17
2025-03-03Kadlec Robert PeterGrant1.5K$8.79
2025-03-03Behner PeterGrant1.8K$8.79
2025-03-03WIINBERG ULFGrant1.6K$8.79
2025-03-03Ryan BarbaraGrant2.0K$8.79
2025-03-03Corvese BrianGrant2.0K$8.79

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-23Shareholder votefiling ↗
2026-05-15ResultsExhibitsfiling ↗
2026-03-31ResultsExhibitsfiling ↗
2026-03-27Otherfiling ↗
2026-03-19Exec/director changefiling ↗
2026-01-02Exec/director changefiling ↗
2025-12-08ResultsExhibitsfiling ↗
2025-09-29Exec/director changeExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-232026-06-170001193125-26-278642 ↗
10-Q2026-05-152026-03-310001193125-26-226804 ↗
8-K2026-05-152026-05-150001193125-26-225369 ↗
10-K2026-03-312025-12-310001193125-26-134813 ↗
8-K2026-03-312026-03-310001193125-26-133346 ↗
8-K2026-03-272026-03-270001193125-26-127931 ↗
8-K2026-03-192026-03-130001193125-26-116219 ↗
8-K2026-01-022025-12-290001193125-26-000916 ↗
8-K2025-12-082025-11-140001193125-25-311229 ↗
10-Q2025-11-142025-09-300001193125-25-282905 ↗
8-K2025-09-292025-09-230001193125-25-221863 ↗
10-Q2025-08-142025-06-300000950170-25-108894 ↗